Alpha Tau Medical Ltd. – NASDAQ:DRTS
Alpha Tau Medical Ltd. stock price today
$3
-0.08
-2.91%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 7 hours
Alpha Tau Medical Ltd. stock price monthly change
+39.19%
month
Alpha Tau Medical Ltd. stock price quarterly change
+39.19%
quarter
Alpha Tau Medical Ltd. stock price yearly change
+10.36%
year
Alpha Tau Medical Ltd. key metrics
Market Cap | 212.56M |
Enterprise value | 189.24M |
P/E | -5.52 |
EV/Sales | N/A |
EV/EBITDA | -5.96 |
Price/Sales | N/A |
Price/Book | 1.79 |
PEG ratio | 0.17 |
EPS | -0.42 |
Revenue | N/A |
EBITDA | -34.38M |
Income | -28.95M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAlpha Tau Medical Ltd. stock price history
Alpha Tau Medical Ltd. stock forecast
Alpha Tau Medical Ltd. financial statements
| Jun 2023 | 0 | -8.69M | |
|---|---|---|---|
| Sep 2023 | 0 | -4.91M | |
| Dec 2023 | 0 | -7.36M | |
| Mar 2024 | 0 | -7.98M |
| Sep 2025 | 750K | -8.55M | -1140.8% |
|---|---|---|---|
| Dec 2025 | 1.3M | -9.71M | -747.01% |
| Mar 2026 | 5.17M | -11.81M | -228.56% |
| Jun 2026 | 7.52M | -12.80M | -170.3% |
Analysts Price target
Financials & Ratios estimates
| 2023-11-16 | -0.12 | -0.07 |
|---|---|---|
| 2024-03-07 | -0.13 | -0.11 |
| 2024-05-20 | -0.13 | -0.11 |
| Jun 2023 | 111206000 | 18.64M | 16.76% |
|---|---|---|---|
| Sep 2023 | 106739000 | 16.88M | 15.82% |
| Dec 2023 | 107388000 | 22.91M | 21.34% |
| Mar 2024 | 102444000 | 23.37M | 22.82% |
| Jun 2023 | 3.78K | 0 | 0 |
|---|---|---|---|
| Sep 2023 | -3.78K | 0 | 0 |
| Dec 2023 | 0 | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 |
Alpha Tau Medical Ltd. alternative data
| Aug 2023 | 94 |
|---|---|
| Sep 2023 | 94 |
| Oct 2023 | 94 |
| Nov 2023 | 94 |
| Dec 2023 | 94 |
| Jan 2024 | 94 |
| Feb 2024 | 94 |
| Apr 2024 | 121 |
| May 2024 | 121 |
| Jun 2024 | 121 |
| Jul 2024 | 121 |
Alpha Tau Medical Ltd. other data
0.93%
-0.41%
of DRTS is owned by hedge funds
593.76K
+49.79K
shares is hold by hedge funds
-
What's the price of Alpha Tau Medical Ltd. stock today?
One share of Alpha Tau Medical Ltd. stock can currently be purchased for approximately $3.
-
When is Alpha Tau Medical Ltd.'s next earnings date?
Unfortunately, Alpha Tau Medical Ltd.'s (DRTS) next earnings date is currently unknown.
-
Does Alpha Tau Medical Ltd. pay dividends?
No, Alpha Tau Medical Ltd. does not pay dividends.
-
How much money does Alpha Tau Medical Ltd. make?
Alpha Tau Medical Ltd. has a market capitalization of 212.56M. Alpha Tau Medical Ltd. made a loss 29.16M US dollars in net income (profit) last year or -$0.11 on an earnings per share basis.
-
What is Alpha Tau Medical Ltd.'s stock symbol?
Alpha Tau Medical Ltd. is traded on the NASDAQ under the ticker symbol "DRTS".
-
What is Alpha Tau Medical Ltd.'s primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Alpha Tau Medical Ltd.?
Shares of Alpha Tau Medical Ltd. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Alpha Tau Medical Ltd. have?
As Jul 2024, Alpha Tau Medical Ltd. employs 121 workers.
-
When Alpha Tau Medical Ltd. went public?
Alpha Tau Medical Ltd. is publicly traded company for more then 4 years since IPO on 8 Mar 2021.
-
What is Alpha Tau Medical Ltd.'s official website?
The official website for Alpha Tau Medical Ltd. is alphatau.com.
-
How can i contact Alpha Tau Medical Ltd.?
Alpha Tau Medical Ltd. can be reached via phone at +972 3 577 4115.
Alpha Tau Medical Ltd. company profile:
Alpha Tau Medical Ltd.
alphatau.comExchange:
NASDAQ
Full time employees:
121
Industry:
Biotechnology
Sector:
Healthcare
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
5 Kiryat Hamada Street
Jerusalem, 9777605
Jerusalem, 9777605
CIK: 0001871321
ISIN: IL0011839383
CUSIP: M0740A108
